ABUS

Arbutus Biopharma Corporation (ABUS)

About Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Details

Daily high

$3.92

Daily low

$3.81

Price at open

$3.91

52 Week High

$4.72

52 Week Low

$1.69

Market cap

724.9M

Dividend yield

0.00%

Volume

636,889

Avg. volume

1.5M

P/E ratio

-8.69

Arbutus Biopharma Corporation News